NCT01758042View on ClinicalTrials.gov

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2027

Conditions
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Chronic Myelogenous Leukemia (CML)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL)Hodgkin DiseaseMultiple MyelomaMyelodysplastic Syndrome (MDS)Aplastic AnemiaAL AmyloidosisDiamond Blackfan AnemiaMyelofibrosisMyeloproliferative DiseaseSickle Cell AnemiaAutoimmune DiseasesThalassemia
Interventions
PROCEDURE

Haploidentical Bone Marrow/Kidney

Combined bone marrow and kidney transplantation using a haploidentical donor.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01758042 - Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders | Biotech Hunter | Biotech Hunter